Aah, not sure if I topped up too late at 1.95. Duit masuk so slow. Hopefully after the stimulus package is announced, it will slowly climb back up to above 3.
Either we will move onto a post-apocalyptic society or the stocks will make a comeback like every other crisis before this.
If the first one was to happen, there is not much difference between wasting your money on stocks compared to anything else. Even stocking on supplies will not help you on the long run.
However, if the markets recover, like they do all the time, then you would be buying the stocks when they cheap, making you a hefty profit. But this might require a long patience, and unfortunately not many people have that.
Don't look too good for Greatech as China recovered and US & Europe is suffering.
Taken from latest quarter result:
The Group is not swerved by the recent COVID-19 pandemic as the Group’s purchases are mainly from the US and European countries. The Group has sufficient materials to fulfil orders received to-date. China customers accounted for less than 1% of the Group’s revenue in 2019. We do not foresee any material adverse impact on the Group’s financial performance.
Todos Medical Ltd. (OTCQB: TOMDF) announced earlier this week the "publication of data from a human clinical study in the scientific journal Analytical Chemistry entitled 'Differential Diagnosis of the Etiologies of Bacterial and Viral Infections Using Infrared Microscopy of Peripheral Human Blood Samples and Multivariate Analysis'. The data demonstrate that the use of the Fourier-transform infrared (FTIR) spectroscopy technique on peripheral blood samples yields a differential diagnosis when seeking to make a clinical diagnosis between patients with viral infections, bacterial infections and healthy controls.
'With the recent explosion of novel coronavirus (2019-nCoV) worldwide, definitively diagnosing viral infections versus bacterial or other types of infections that present with similar symptoms has become paramount in order to appropriately triage patients and guide treatment decisions for healthcare professionals,' said Gerald Commissiong, President & CEO of Todos Medical.
'Todos' proprietary FTIR blood testing platform that focuses on the immune system's reaction to cancer has received CE Marks in Europe for the diagnosis of breast cancer and colon cancer, has recently achieved strong analytical performance results from our proprietary sample preparation methods, and is currently enrolling a pre-commercial breast cancer study in Romania with distribution partner Orot+ (a division of Orot Luces) ahead of an expected commercial launch in Romania later this year.
Based on these recent successes and this publication from the Company's licensors at Ben Gurion University, we have now formally begun to evaluate the commercial feasibility of applying our technology towards the diagnosis of bacterial and viral infections, including coronavirus.
............
[DUFU] Notice of Interest of Substantial Shareholders - EASTSPRING INVESTMENTS BERHAD on 03-Apr-2020
Total no of securities after change Direct (units) 12,898,620 Direct (%) 5.03
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
MatthewBong
53 posts
Posted by MatthewBong > 2020-03-25 13:50 | Report Abuse
TIME TO GOING DOWN